LOAMU
TAK icon

Lombard Odier Asset Management (USA)’s Takeda Pharmaceutical TAK Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$885K – 293
2019
Q2 		$885K Hold
50,000
– – 0.07% 181
2019
Q1 		$1.02M Hold
50,000
– – 0.08% 171
2018
Q4 		$841K Buy
+50,000
New +$844K 0.07% 182

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s TAK Position: Q3 2019 in Review

Lombard Odier Asset Management (USA) sold out of Takeda Pharmaceutical (TAK) in Q3 2019, closing a stake of 50,000 shares — an estimated $885K sold.

Lombard Odier Asset Management (USA) first reported a position in TAK in Q4 2018 and held it in 3 quarters. The position peaked at $1.02M in Q1 2019. 317 funds tracked by Wall St. Rank hold TAK as of Q3 2019.

  • Lombard Odier Asset Management (USA) reported no remaining Takeda Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 50,000 Takeda Pharmaceutical shares in Q3 2019, an estimated $885K.
  • Lombard Odier Asset Management (USA) first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s Takeda Pharmaceutical position peaked at $1.02M in Q1 2019.
  • 317 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2019, filed 14 Nov 2019.